Targeting alzheimer’s in the earlier stages of its progress can lead to benefits in the treatment and arouses chances of recovery of the brain functions lost. The hope being that future treatment can help target the disease in its early stages and help rehabilitate the damaged part. Furthermore, research of new strategies would help in the earlier recognition of active cases and help in prescribing suitable medication routes from the get-go.
Current diagnosis tactics rely largely on inspecting and recording mental decline, at which point alzheimer’s has already caused severe brain damage. Recovery from such a point gets harder, and progression into a stage of utter oblivion starts to settle in. Researchers hope to discover an easy and accurate ways to find out about alzheimer’s before the devastating symptoms of alzheimer’s settle in.
Seeking such biomarkers offer one of the most promising paths. A biomarker is something that can be measured to accurately and reliably indicate the presence of a disease.
Several potential biomarkers have been studied for their ability to indicate the early stages of alzheimer’s disease. One of the parameters under study would be beta-amyloid and tau levels in cerebrospinal fluid and brain change detectable by imaging. Recent research suggests that these indicators may change at different stages of the disease process.
Research is being conducted to make sure that laboratory methods used to measure the biomarker must be shown to be stable and reliable. As the researchers continue to find prudent relevance of biomarkers in the early detection of alzheimer’s, there are several other FDA-approved tools that can help in the detection of alzheimer’s.
Brain Imaging/ Neuroimaging
Neuroimaging is regularly used today for the early detection of Alzheimer’s. Research continues to evolve on promising and advanced brain imaging techniques. Tests that can help early recognition of alzheimers.
Provides information about the shape, position, or volume of the brain tissue. Structural techniques include magnetic resonance imaging (MRI) and computed tomography (Ct). Structural imaging has been able to show shrinkage in specific regions of the brain, such as the hippocampus, which can be seen as an early sign of alzheimer’s; scientists have globally established the standards for the standardized values of the brain for volume loss. These established standards are profoundly helpful in attending to a presence of a disease or disease progression.
These tests have become a common pursuit while testing for alzheimer’s as their structural imaging can help in diagnosing other conditions which can have symptoms similar to that of alzheimer’s. Structural imaging such as MRI can rival tumors, evidence of small or large strokes, damage from severe head trauma, or a build-up of fluid in the brain. These may be able to detect underlying conditions that may help in designing unique treatment plans according to the particular needs of a patient.
Stem Cell therapy treatment in the case of alzheimer’s reveals many hurdles and helps preserve the existing tissue more than the actual regeneration of brain tissue. Several other therapies can help in improving the life quality of alzheimer’s patients. Viezec care India can help in such cases and help improve upon the quality of life a patient lives.